Britain covid-19 symptoms infection patient Britain

UK company says its inhaled drug could be a 'breakthrough' in covid treatment

Reading now: 511
www.livemint.com

COVID-19 patients, according to data from a trial of more than 100 people in the UK. Interferon beta is a naturally occurring protein, which regulates the body's antiviral responses.The trial, which used interferon beta, showed that patients who were given Synairgen's formulation had a 79% lower risk of developing severe disease compared to placebo.

Patients who received the drug, SNG001, were more than twice as likely to recover from COVID-19 as those on placebo, the company said."We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA